tiprankstipranks
Actinogen Medical Limited (AU:ACW)
ASX:ACW

Actinogen Medical Limited (ACW) Share Price & Analysis

7 Followers

ACW Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.01 - AU$0.05
Previous CloseAU$0.03
Volume536.64K
Average Volume (3M)2.40M
Market Cap
AU$76.94M
Enterprise ValueAU$60.74M
Total Cash (Recent Filing)AU$16.37M
Total Debt (Recent Filing)AU$165.27K
Price to Earnings (P/E)
Beta1.31
Aug 28, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,326,920,711
10 Day Avg. Volume5,170,968
30 Day Avg. Volume2,399,282
Standard Deviation0.40
R-Squared0.02
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

6.14%0.00%<0.01%93.86%
<0.01% Other Institutional Investors
93.86% Public Companies and
Individual Investors

ACW FAQ

What was Actinogen Medical Limited’s price range in the past 12 months?
Actinogen Medical Limited lowest share price was AU$0.01 and its highest was AU$0.05 in the past 12 months.
    What is Actinogen Medical Limited’s market cap?
    Currently, no data Available
    When is Actinogen Medical Limited’s upcoming earnings report date?
    Actinogen Medical Limited’s upcoming earnings report date is Aug 28, 2024 which is in 68 days.
      How were Actinogen Medical Limited’s earnings last quarter?
      Actinogen Medical Limited released its earnings results on Feb 25, 2024. The company reported -AU$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.006.
        Is Actinogen Medical Limited overvalued?
        According to Wall Street analysts Actinogen Medical Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Actinogen Medical Limited pay dividends?
          Actinogen Medical Limited does not currently pay dividends.
          What is Actinogen Medical Limited’s EPS estimate?
          Actinogen Medical Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Actinogen Medical Limited have?
          Actinogen Medical Limited has 2,482,050,000 shares outstanding.
            What happened to Actinogen Medical Limited’s price movement after its last earnings report?
            Actinogen Medical Limited reported an EPS of -AU$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Actinogen Medical Limited?
              Currently, no hedge funds are holding shares in AU:ACW
              ---

              Actinogen Medical Limited Stock Smart Score

              Company Description

              Actinogen Medical Limited

              Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological and metabolic diseases. Geographically, it operates and derives revenue from Australia.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Actinogen Medical Limited
              Anavex Life Sciences
              Axsome Therapeutics
              Biohaven Ltd.
              Cytokinetics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis